We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sarcopenia Can Predict Post-Hepatectomy Survival

By HospiMedica International staff writers
Posted on 03 Oct 2013
A new study suggests that sarcopenia can predict worse overall survival for hepatocellular carcinoma (HCC) following partial hepatectomy.

Researchers at Kyushu University (Fukuoka, Japan) retrospectively collected data for 186 consecutive patients who underwent hepatectomy for HCC with curative intent between January 2004 and December 2009. More...
Patients were assigned to one of two groups according to the clinical presence or absence of sarcopenia. They were also assessed by computerized tomography (CT) measurement of muscle mass at the level of the third lumbar vertebra, and clinic-pathological, surgical outcome, and long-term survival data were analyzed.

The results showed that sarcopenia was present in 40.3% of the patients, and was significantly correlated with female sex, lower body mass index (BMI), and liver dysfunction, as indicated by abnormal serum albumin levels and indocyanine green retention test at 15-minute values. In patients with and without sarcopenia, the 5-year overall survival rate was 71% and 83.7% respectively, and the 5-year recurrence-free survival rate was 13% and 33.2% respectively. Analysis revealed that reduced skeletal muscle mass was also predictive of an unfavorable prognosis. The study was published in the October 2013 issue of the British Journal of surgery (BJS).

“The present study investigated the effect of sarcopenia on short- and long-term outcomes following partial hepatectomy for hepatocellular carcinoma, and aimed to identify prognostic factors,” said lead author Norifumi Harimoto, MD, PhD, and colleagues of the department of surgery and science. “Sarcopenia was predictive of worse overall survival, even when adjusted for other known predictors.”

Sarcopenia (from the Greek, meaning "poverty of flesh") is the degenerative loss of skeletal muscle mass. It is characterized first by muscle atrophy, along with a reduction in muscle tissue quality, caused by such factors as replacement of muscle fibers with fat, an increase in fibrosis, changes in muscle metabolism, oxidative stress, and degeneration of the neuromuscular junction. Combined, these changes lead to progressive loss of muscle function and frailty. Sarcopenia can thus be thought of as a muscular analog of osteoporosis, also caused by inactivity and counteracted by exercise. The combination of osteoporosis and sarcopenia results in the significant frailty often seen in the elderly population.

Related Links:

Kyushu University



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.